ChartRow logo
MDLN
Medline Inc.Stock · Health Care
$35.58+$0.08 (+0.23%)as of market close, Aug 13, 2026
☾ After hours:$35.58+0.00%3:59 PM ET
CompareLLYUNHJNJABBVISRGTMO

MDLN financial statements

The full income statement, balance sheet, and cash-flow statement for Medline Inc. (MDLN), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2025-12 810.0M2026-03 824.8M2026-06 860.9M+6.3% over 2 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23
Revenue
28.4B
YoY+11.5%
25.5B
YoY+9.8%
23.2B
7.52B
YoY+7.8%
6.98B
YoY+18.5%
5.88B
5.31B
YoY+9.9%
4.83B
YoY+4.2%
4.63B
Operating income
2.21B
YoY+3.1%
2.15B
YoY+71.7%
1.25B
Interest expense
945M
YoY-17.4%
1.14B
YoY-5.7%
1.21B
Interest & investment income
133M
YoY-52.5%
280M
YoY+18.1%
237M
Other non-operating income
-64.0M
YoY-48.8%
-43.0M
YoY-4400.0%
1.00M
Pre-tax income
1.25B
YoY+0.2%
1.25B
YoY+372.0%
264M
Income tax
91.0M
YoY+97.8%
46.0M
YoY+53.3%
30.0M
1.16B
YoY-0.3%
1.16B
YoY+397.0%
234M
-$0.01
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23
10.7B
YoY+29.1%
8.27B
38.5B
YoY+7.0%
36.0B
2.49B
YoY+2.0%
2.44B
19.2B
YoY-1.3%
19.5B
10.7B
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23
1.74B
YoY-1.4%
1.77B
YoY+5.0%
1.69B
-474M
YoY+68.3%
-1.49B
YoY-378.5%
-312M
399M
YoY+124.7%
-1.61B
YoY-744.5%
-191M
FX effect on cash
23.0M
YoY+1050.0%
2.00M
YoY-50.0%
4.00M
Net change in cash
1.69B
YoY+226.7%
-1.33B
YoY-212.6%
1.19B
Interest paid
944M
YoY-7.6%
1.02B
YoY-9.2%
1.13B
Income taxes paid
62.0M
YoY-38.6%
101M
YoY+94.2%
52.0M
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23
Market cap
34.0B
P/E
29.4×
P/S
1.2×
P/B
3.2×
P/FCF
26.2×
3.4%
3.8%
Source filing10-K10-K10-K

About this data

Source: MDLN's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all MDLN filings on SEC EDGAR → Not investment advice.